amfAR - Therapeutic Immune Reprogramming in Cancer Request for Proposals 2026

Published: June 23, 2026
Deadline: June 29, 2026
Category: Grants

amfAR is currently accepting applications for its Therapeutic Immune Reprogramming in Cancer Request for Proposals 2026. Interested applicants are encouraged to click here to learn more about this opportunity and apply for it

About amfAR - Therapeutic Immune Reprogramming in Cancer Request for Proposals

This amfAR funding opportunity supports cancer immunology research focused on immune reprogramming.The call is designed for researchers investigating how ineffective immune states in cancer can be restored, redirected, or amplified to improve anti-tumor immunity.It supports mechanistic, preclinical, and translational projects with strong relevance to future therapeutic development.

Sponsor Organisation: amfAR

Benefits of amfAR - Therapeutic Immune Reprogramming in Cancer Request for Proposals

Award amount: Up to $480,000, including up to 20% indirect costs

amfAR - Therapeutic Immune Reprogramming in Cancer Request for Proposals Requirements

Any biomedical researcher holding a research or clinical doctoral degree who is affiliated with a nonprofit research institution, anywhere in the world, is eligible to apply.